EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk of High‐Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population‐Based Screening Cohort

Mingrong Xi, Mengyin Ao, Jing Li iD, Shaokai Zhang, Zhifang Li, Leni Kang, Youlin Qiao iD, Wen Chen, Yin Liu, Lian Xu, Xi Zeng iD, Mingwei Yuan und 4 weitere

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70968 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Mingrong Xi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, West China Second University Hospital & Key Laboratory of Birth Defects and Related Diseases of Women and Ch…. Hauptthemen laut MEDLINE: Human Papillomavirus Viruses, Papillomaviridae, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the risk of cervical intraepithelial neoplasia, grade 2 or worse (≥ CIN2) in women with normal cervical cytology using extended high‐risk human papillomavirus (HR‐HPV) genotyping. This study is a population‐based, nationwide, multi‐center prospective cohort study. A subset of 6853 women with normal cytology and HPV testing results using an extended genotyping assay were included in the analysis. The odds ratio (OR) and adjusted OR (aOR) was calculated using univariate analyses and multivariate logistic regression, with HPV negative and other 9 HR‐HPV‐positive genotypes (HPV 31, 35, 39, 45, 51, 56, 59, 66, and 68) as reference, respectively. The 3‐year cumulative absolute risk was calculated. Over the study period, 87 ≥ CIN 2 cases were identified. Most ≥ CIN 2 cases were positive for HPV 16 (50.6%) or HPV 33/52/58 (46.0%) at baseline. Compared to other 9 h‐HPV, HPV 16 (aOR = 20.5, 95% CI: 8.5–49.5), HPV18 (aOR = 10.1, 95% CI: 3.2–31.8), and HPV 33/52/58 (aOR = 4.8, 95% CI: 2.0–11.8) were significantly associated with higher risk of ≥ CIN 2. HPV 16 and 33 had the highest cumulative absolute risk of ≥ CIN2 (25.9% and 22.2%), followed by HPV 18 (15.4%), HPV 58 (11.3%), and HPV 52 (8.1%). Other 9 h‐HPV had a lower risk of ≥ CIN 2 (4.7%). Extended HPV genotyping beyond HPV 16/18 (e.g., HPV 33, 52, and 58) might be effective for risk stratification in women with normal cervical cytology. The management of HPV‐positive women based on refined genotype‐based risk estimations may be a promising strategy for cervical cancer screening. The study was registered at the Chinese Clinical Trial Registry Center of the World Health Organization International Clinical Trials Registry Platform (Registration number ChiCRT2200055287).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Papillomavirus VirusesPapillomaviridaePapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedYoung AdultCervix UteriChinaEarly Detection of CancerGenotypeGenotyping TechniquesProspective StudiesRisk Assessment

Stichwörter der Autor:innen

HPVcervical screeninggenotypinghigh‐grade cervical intraepithelial neoplasia

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, West China Second University Hospital & Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.
  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Cancer Epidemiology and Prevention, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, The Affiliated Cancer Hospital of Zhengzho…
  • Department of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, China.
  • National Office for Maternal and Child Health Surveillance, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Jing Li, Youlin Qiao, Xi Zeng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xi, M., Ao, M., Li, J., Zhang, S., Li, Z., Kang, L., Qiao, Y., Chen, W., Liu, Y., Xu, L., Zeng, X., Yuan, M., Xue, S., Tang, D., Yao, X. X., & Liao, G. (2026). Risk of High‐Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population‐Based Screening Cohort. Journal of Medical Virology. https://doi.org/10.1002/jmv.70968

Vancouver

Xi M, Ao M, Li J, Zhang S, Li Z, Kang L, et al. Risk of High‐Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population‐Based Screening Cohort. Journal of Medical Virology. 2026. doi:10.1002/jmv.70968

BibTeX
@article{Xi2026,
  author = {Xi, Mingrong and Ao, Mengyin and Li, Jing and Zhang, Shaokai and Li, Zhifang and Kang, Leni and Qiao, Youlin and Chen, Wen and Liu, Yin and Xu, Lian and Zeng, Xi and Yuan, Mingwei and Xue, Shaolong and Tang, Dan and Yao, Xiao Xi and Liao, Guangdong},
  title = {Risk of High‐Grade Cervical Intraepithelial Neoplasia Using human Papillomavirus Extended Genotyping in Chinese Women With Normal Cervical Cytology: A Population‐Based Screening Cohort},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70968}
}
Kostenlos starten →